NCT05710536

Brief Summary

This study is conducted to investigate the safety and efficacy of the formulation containing stem cell secretome and licorice root extract in improving vagina laxity (VL) condition of women in Malaysia. This formulation may stimulate cell rejuvenation and trigger cell renewal efficiently as they contained rich mixture of natural, bioavailable polypeptides and plant extracts and these might help improving the VL condition in women. The study duration is 5 weeks and vagina assessment will be carried out at baseline, week 2 and week 5.The main objectives of this study are:

  1. 1.To assess the vagina laxity of women in Malaysia after using the formulation.
  2. 2.To observe any adverse effect occurrence with the use of the formulation.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable healthy

Timeline
Completed

Started Dec 2023

Typical duration for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 13, 2023

Completed
20 days until next milestone

First Posted

Study publicly available on registry

February 2, 2023

Completed
10 months until next milestone

Study Start

First participant enrolled

December 1, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

March 6, 2026

Status Verified

March 1, 2026

Enrollment Period

11 months

First QC Date

January 13, 2023

Last Update Submit

March 4, 2026

Conditions

Keywords

Vagina laxity

Outcome Measures

Primary Outcomes (3)

  • Change in vagina laxity condition from baseline and at week 2 and week 5 after using the product

    Vagina laxity questionnaire (VLQ) will be used to assess participant's vagina laxity conditions at baseline, week 2 and week 5. This is a self-reported tool where participants will be asking to score their vagina laxity on a scale of 1 to 7 (1= very loose, 2= moderately loose, 3= slightly loose, 4= neither tight nor loose, 5= very tight, 6= moderately tight, 7= very tight)

    Baseline, Week 2 and Week 5

  • Change in vagina tone from baseline and at week 2 and week 5 after using the product

    Vagina tone is measured using a perineometer (measurement of vaginal squeeze pressure). This assessment will be carried out by trained clinician at baseline, week 2 and week 5 and it will determine participant vagina tone.

    Baseline, Week 2 and Week 5

  • Adverse effect after using the formulation

    Based on adverse effect occurrence on participants that occur during study period (5 weeks)

    week 5

Study Arms (1)

Formulation X

EXPERIMENTAL

Participants will use the formulation once every 72 hour for 5 weeks

Other: Formulation X

Interventions

This formulation containing stem cell secretome and liquorice root extract

Formulation X

Eligibility Criteria

Age40 Years - 55 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Malaysian women ( age 40 to 55 years old)
  • Complaint of vagina laxity
  • Willingness to participate in the study

You may not qualify if:

  • Pregnant and breastfeeding women
  • Doing any surgical or non-surgical procedures to improved vaginal laxity condition such as laser and radiofrequency before participating in the study that might affect the study outcome
  • Presence of illness or taking any medication that might impact the study outcome or participants well-being

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ungku Shahrin Medical Aesthetic Research & Innovation (USMARI) Centre

Petaling Jaya, Selangor, 47810, Malaysia

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 13, 2023

First Posted

February 2, 2023

Study Start

December 1, 2023

Primary Completion

October 31, 2024

Study Completion

December 30, 2024

Last Updated

March 6, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations